Vernalis Therapeutics

Berwyn, Pennsylvania based Vernalis Therapeutics Inc, is a distributor of pharmaceutical products, with a focus on the sales and marketing of prescription cough cold products in the US market.  Vernalis Therapeutics Inc, is a U.S. subsidiary of Vernalis plc, a UK based company, listed on AIM and founded in 2003 with an historic focus on drug discovery and clinical development.

Vernalis Therapeutics Inc, is dedicated to building a broad portfolio of unique long-acting formulations of branded prescription cough cold products for the US market.

 

 

Latest News

Vernalis Notes the Acquisition of RedoxTherapies by Juno Therapeutics

Vernalis plc ("Vernalis" or the "Company") notes the announcement by Juno Therapeutics, Inc. ("Juno") (NASDAQ: JUNO) that RedoxTherapies, Inc. ("RedoxTherapies") and Juno have entered into a share purchase agreement, pursuant to which Juno acquired the outstanding shares of RedoxTherapies.

Read more ...

Fact Sheet

For more information on Vernalis, click below to download a copy of our fact sheet

 

Factsheet-Nov14

 

 

 

 

Contact Vernalis Therapeutics

T: 1-484-913-0700
F: 1-610-651 5976

Contact information
Maps and directions
Contact form